Blueprint Medicines initiated with an Overweight at JPMorgan
JPMorgan initiated coverage of Blueprint Medicines (BPMC) with an Overweight rating and $126 price target Blueprint is a biotech company ...
Jasper Therapeutics to Participate at Upcoming Investor Conferences
Live webcasts of the presentations will be available on the Events & News – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's ...